Medico Remedies Limited (MEDICO) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Medico Remedies Limited stock ₹22.32, price ₹18.31, upside +21.9%, quality 50 out of 100. Rating: undervalued. Calculated from audited financials with 15 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Medico Remedies Limited
MEDICO · NSESolid company, but only slightly cheap (18% below fair value) and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 13, 2026.
How to read this chart
54‑month range ₹17.11 – ₹96.70 · fair‑value band ₹10.75 – ₹29.01 · the ₹18.31 price screens below the ₹22.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 13, 2026.
Every Wednesday you see whether Medico Remedies is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India.
Show moreShow less
The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations.
It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.
Stock analysis
Medico Remedies Limited (MEDICO) currently trades at ₹18.31, while our model-based Fair Value estimate is ₹22.32, implying the stock looks roughly 18% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹33.90 per share, and 10 of the 15 models we run sit above the ₹18.31 price.
Bear case: the Asset-Based group reads lowest at ₹6.14, and 5 of the 15 models stay below the price. Data coverage for this calculation is low.
Scenario range: ₹10.75 (bear) to ₹29.01 (bull), the price of ₹18.31 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 50/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Medico Remedies Limited reported revenue of ₹2.1B in FY2026 versus ₹1.2B in FY2022, a compound +14.3%/yr. Reported net income was ₹131M in FY2026, compounding +28.5%/yr from FY2022.
Key figures
Market cap ₹1.5B (≈ $16.1M) Micro · P/E ratio 11.0 · P/S ratio 0.64 · EPS (TTM) ₹1.67 · Net margin 5.8% · Return on equity 19.0% · Return on assets (EBIT) 13.0% (5-year average) · Operating margin 3.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 44 out of 100 (medium confidence).
What moves the price
The share trades about 66% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −27% fair-value upside, at 22%, MEDICO screens cheaper than that median.
Fair Value models
All 15 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch MEDICO, get fair value alerts →
Compare Medico Remedies Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 604 stocks
Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Stock screener with 62 metrics
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Zoetis Inc ZTS | $83.82 | $113.53 | +35% | vs MEDICO |
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥48.07 | ¥53.04 | +10% | vs MEDICO |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,880 | ₹1,983 | +5% | vs MEDICO |
| Haleon plc HLN | $9.17 | $8.47 | −8% | vs MEDICO |
| Merck KGaA MRK | €149.60 | €108.83 | −27% | vs MEDICO |
| Galderma Group GALD | CHF 191.40 | CHF 112.30 | −41% | vs MEDICO |
| Takeda Pharmaceutical Company TAK | $21.43 | $11.20 | −48% | vs MEDICO |
| Sandoz Group SDZ | CHF 84.60 | CHF 40.54 | −52% | vs MEDICO |
| Teva Pharmaceutical Industries Limited TEVA | $44.50 | $20.74 | −53% | vs MEDICO |
| Divi's Laboratories Limited DIVISLAB | ₹11,442 | ₹1,567 | −86% | vs MEDICO |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Medico Remedies Limited (MEDICO) overvalued or undervalued?
What is the fair value of MEDICO?
What is the quality score of MEDICO?
What is the price target for Medico Remedies Limited (MEDICO)?
What is the Medico Remedies Limited stock forecast for 2026?
What is the revenue of Medico Remedies Limited (MEDICO)?
What is the intrinsic value of Medico Remedies Limited (MEDICO)?
Is Medico Remedies Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of MEDICO?
How much is Medico Remedies Limited worth?
What do the bullish and bearish scenarios say about MEDICO?
What is the P/E ratio of MEDICO?
How solid is the balance sheet of Medico Remedies Limited (MEDICO)?
How far is MEDICO from its 52-week high?
Which stocks are comparable to Medico Remedies Limited?
Is Medico Remedies Limited stock attractive at the current price?
How is the fair value of MEDICO calculated?
Is it still worth investing in stocks now?
What is the share price of Medico Remedies Limited (MEDICO)?
What should I pay attention to with Medico Remedies Limited right now?
Where does the earnings growth of Medico Remedies Limited (MEDICO) come from?
Key figures of Medico Remedies Limited
How large is the market capitalisation of Medico Remedies Limited (MEDICO)?
What is the P/S ratio of Medico Remedies Limited (MEDICO)?
What are the earnings per share of Medico Remedies Limited (MEDICO)?
What is the net margin of Medico Remedies Limited (MEDICO)?
What is the return on equity of Medico Remedies Limited (MEDICO)?
What is the EBIT return on assets of Medico Remedies Limited (MEDICO)?
What is the operating margin of Medico Remedies Limited (MEDICO)?
How fast is revenue growing at Medico Remedies Limited (MEDICO)?
How fast are earnings growing at Medico Remedies Limited (MEDICO)?
How much free cash flow does Medico Remedies Limited (MEDICO) generate?
How much net debt does Medico Remedies Limited (MEDICO) carry?
Watch Medico Remedies Limited in the live analysis
One click puts Medico Remedies Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.